News Article

ECHA finds health benefits outweigh costs of REACH restrictions

European Chemicals Agency (ECHA) study analyzes costs and benefits of REACH restrictions proposed during 2016-2020; finds public health benefits of €2.1 billion per year outweigh costs of €0.5 billion per year; restrictions protect over seven million EU citizens from cancers, sexual development disorders, asthma, skin allergies; prevents annual release of 100 000 tons of polluting chemicals

News Article

EU notifies C9-C14 PFCA restriction to WTO

European Union notifies World Trade Organization of proposed amendment to REACH Restriction List (Annex XVII) to restrict manufacturing, use, placing on the market and import of C9-C14 perfluorocarboxylic acids (PFCAs), their salts and related substances within the EU; long-chain PFCAs can be present in food contact materials as impurities but also degradation products of long-chain fluorotelomers

News Article

EDCs and manufacturing doubt

Prominent EDC researchers publish rebuttal to critique of WHO/UNEP State of the Science 2012 report, accuse industry-funded scientists to deliberately confuse non-experts to delay regulatory action

News Article

Focus on EDC controversy

Health & Environment article outlines debate around 2012 WHO/UNEP report on EDCs; discusses value of state-of-the-science reviews and need for systematic review methods in complex research problems